HM Capital

Dallas BioPharma Closes $23M Series C Funding

by | Sep 21, 2023
Osteal Therapeutics, a clinical-stage biopharmaceutical company, says it's developing "a new category" of combination therapies for orthopedic infections. The new funding round, led by Asteroid Partners, will help Osteal accelerate preparation for commercial launch of VT-X7, its lead therapy for the treatment of periprosthetic joint infection, the company said.
MORE
funding
Follow the Money: Rent-A-Center Nabs $19M Investment, Playful Studios Receives $23M; ReadyRosie Acquired
by | Sep 5, 2019
In this weekly roundup of funding, merger, and acquisition activity involving companies in North Texas, you’ll also find news from ACIS, TPG, HM Capital, and Fleco Industries.
MORE